Bienvenida A.
- Country
- Spain
- Department
- Aparicio
Research Overview
Data & Insights
Has run more than one trial at 0 of 43 partner sites.
Specializations
Hematologic Oncology
The investigator focuses on malignant blood disorders, including acute myeloid leukemia, myelodysplastic syndromes, and various lymphomas.
- Acute myeloid leukemia (AML)
- Myelodysplastic syndrome (MDS)
- Non‑Hodgkin lymphoma (NHL)
- Multiple myeloma (MM)
- Chronic lymphocytic leukemia (CLL)
Research aims to improve outcomes for patients with high‑risk hematologic malignancies.
Solid Tumor Oncology
Clinical work includes advanced and metastatic solid cancers such as non‑small cell lung cancer, renal cell carcinoma, and breast cancer.
- Non‑small cell lung cancer (NSCLC)
- Renal cell carcinoma (RCC)
- Triple‑negative breast cancer (TNBC)
- Colorectal carcinoma
- Ovarian carcinoma
Efforts target novel targeted therapies and immuno‑oncology strategies.
Autoimmune & Inflammatory Disorders
Investigations address systemic immune‑mediated diseases, notably systemic lupus erythematosus, inflammatory bowel disease, and psoriatic arthritis.
- Systemic lupus erythematosus (SLE)
- Crohn’s disease
- Ulcerative colitis
- Psoriatic arthritis
- Atopic dermatitis
Therapeutic goals include disease control and reduction of organ damage.
Neurodegenerative & Neurological Diseases
The investigator contributes to research on neuro‑degeneration, covering Alzheimer’s disease, Amyotrophic lateral sclerosis, and multiple sclerosis.
- Alzheimer’s disease (AD)
- Amyotrophic lateral sclerosis (ALS)
- Multiple sclerosis (MS)
- Parkinson’s disease
- Frontotemporal dementia
Studies aim to identify disease‑modifying treatments and biomarkers.
Cardiovascular & Metabolic Disorders
Key interests include cardiovascular risk conditions such as atherosclerotic cardiovascular disease, heart failure phenotypes, and metabolic liver disease.
- Atherosclerotic cardiovascular disease (ASCVD)
- Heart failure with reduced ejection fraction (HFrEF)
- Non‑alcoholic steatohepatitis (NASH)
- Hypertrophic cardiomyopathy
- Type 2 diabetes mellitus
Research emphasizes novel therapeutic pathways to mitigate cardiovascular morbidity.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.